TUFM

Elongation factor Tu, mitochondrial · P49411 · TUFM on Sugi Atlas →

1,715 patent compounds predicted against TUFM, 1,460 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Gilteritinib Gilteritinib (SCHEMBL282229) 1.00 1/20
SCHEMBL328303 SCHEMBL328303 0.94 1/20
Gilteritinib Gilteritinib (SCHEMBL21819929) 0.92 1/20
Gilteritinib Gilteritinib (SCHEMBL22684910) 0.91 1/20
Gilteritinib Gilteritinib (SCHEMBL22684912) 0.91 1/20
SCHEMBL21455071 SCHEMBL21455071 0.89 1/20
SCHEMBL22652336 SCHEMBL22652336 0.89 1/20
SCHEMBL10156928 SCHEMBL10156928 0.89 1/20
Gilteritinib Gilteritinib (SCHEMBL22684909) 0.88 1/20
Gilteritinib Gilteritinib (SCHEMBL22684903) 0.87 1/20
SCHEMBL22694087 SCHEMBL22694087 0.87 1/20
SCHEMBL21426963 SCHEMBL21426963 0.86 1/20
SCHEMBL21427160 SCHEMBL21427160 0.86 1/20
Gilteritinib Gilteritinib (SCHEMBL23149445) 0.86 1/20
SCHEMBL25483843 SCHEMBL25483843 0.86 1/20
SCHEMBL25483845 SCHEMBL25483845 0.86 1/20
SCHEMBL282490 SCHEMBL282490 0.85 1/20
SCHEMBL282491 SCHEMBL282491 0.85 1/20
Gilteritinib Gilteritinib (SCHEMBL22684907) 0.85 1/20
SCHEMBL22694094 SCHEMBL22694094 0.85 1/20

Clinical trials — most relevant to TUFM by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Study of the Efficacy and Safety of MT1621 in Thymidine Kinase 2 (TK2) Deficiency (Treatment naïve) PHASE3WITHDRAWN
Biologic Correlative Taxotere/AC PHASE2COMPLETED
A Study of Bezafibrate in Mitochondrial Myopathy PHASE2COMPLETED
Efficacy and Tolerability of Tauroursodeoxycholic Acid in Amyotrophic Lateral Sclerosis PHASE2COMPLETED
Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D) EARLY_PHASE1COMPLETED
Effect of Dietary Nitrate on Immobilization-induced Changes in Skeletal Muscle in Young Healthy Men nanRECRUITING
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Measuring Protein Turnover in Humans Across the Lifespan by Metabolic Labeling With Deuterium Oxide nanRECRUITING
Gastrointestinal Dysfunction in Children Affected With Mitochondrial Disorders nanCOMPLETED
Mitochondrial Activity and Myosteatosis in the Cachexia of Cancers of the Upper Aerodigestive Tract nanUNKNOWN
Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise nanCOMPLETED
Nicotinamide Riboside and Mitochondrial Biogenesis nanCOMPLETED
Effect of Diaphragm Stimulation During Surgery nanCOMPLETED
Mitochondrial Assessment in Critical Ill Patients in Intensive Care nanNOT_YET_RECRUITING
Mitoquines in COPD nanUNKNOWN
Tissue Sample Study for Mitochondrial Disorders nanENROLLING_BY_INVITATION
Effect of Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice on Mitochondrial DNA in Peripheral Blood Leukocytes nanNOT_YET_RECRUITING
Skeletal Muscle Regeneration in Survivors of Critical Illness: How to Prevent Satellite Cell Failure? nanRECRUITING
Mitochondrial Dysfunction in Diabetes nanCOMPLETED
Relationship Between Mitochondrial Dysfunction and Fatique in Cancer Patients Following External Beam Radiation Therapy nanCOMPLETED
Exercise-mediated Rescue of Mitochondrial Dysfunctions Driving Insulin Resistance nanCOMPLETED
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Nutraceutical Composition Containing Natural Products Derivatives on the Modulation of the Endocrine Neuroimmune Axis nanCOMPLETED
Cardiac Mitochondrial Function in Explanted Human Hearts nanUNKNOWN
Mitochondrial Dysfunctions Driving Insulin Resistance nanCOMPLETED
Exercise Training Effects on Muscle Function in Adults With Mitochondrial Myopathy nanRECRUITING
Effect of Supplementing a Mixed Macronutrient Beverage With Graded Doses of Leucine on Myofibrillar Protein Synthesis nanCOMPLETED
Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells nanRECRUITING
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a TUFM binder may also engage these)

ProteinNameSimilarity
P49410 1.000 P49410 →
P85834 1.000 P85834 →
Q8BFR5 1.000 Q8BFR5 →
Q9Y700 0.999 Q9Y700 →
Q54HB2 0.999 Q54HB2 →
Q32PH8 0.998 Q32PH8 →
Q9ZT91 0.998 Q9ZT91 →
P62631 0.998 P62631 →
P02992 0.996 P02992 →
Q3ZXX3 0.996 Q3ZXX3 →
B0W010 0.995 B0W010 →
EEF1A2 Elongation factor 1-alpha 2 0.995 landscape →
P02991 0.995 P02991 →
P17746 0.995 P17746 →
A5FQQ5 0.994 A5FQQ5 →
Q40450 0.994 Q40450 →
Q43364 0.994 Q43364 →
Q5R8Z3 0.994 Q5R8Z3 →
P05197 0.994 P05197 →
P55823 0.993 P55823 →
A9ETD1 0.993 A9ETD1 →
P58252 0.993 P58252 →
P50372 0.993 P50372 →
Q2K9L8 0.993 Q2K9L8 →
P25039 0.993 P25039 →
A7A0X4 0.993 A7A0X4 →
Q3Z7S9 0.993 Q3Z7S9 →
A4FWF0 0.993 A4FWF0 →
B5VN01 0.993 B5VN01 →
Q754I9 0.993 Q754I9 →